Workflow
Allscripts Healthcare Solutions (MDRX) Investor Presentation - Slideshow
Veradigm Veradigm (US:MDRX)2022-03-07 19:11

Transaction Overview - Allscripts has reached an agreement to sell the net assets of its Hospitals & Large Physician Practices business segment to Harris Health for up to $700 million[3] - The purchase consideration includes a fixed price of $670 million paid at closing, plus contingent consideration up to $30 million based on revenue performance[3] - The after-tax proceeds from the deal are expected to be approximately $600 million[9] Business Segment Performance (Hospitals & Large Physician Practices) - The business segment's TTM revenue through 12/31/21 was $928 million, and TTM adjusted EBITDA was $145 million[7] - Management expects the business segment's revenue to be down approximately 3-4% year-over-year in 2022[7] - Management expects the business segment's adjusted EBITDA to be down approximately 10-15% year-over-year in 2022[7] - The business segment is estimated to generate approximately $50-60 million in free cash flow in 2022[7] Veradigm Business - Veradigm's overall revenue is expected to grow 6-7% in 2022[16] - Veradigm's adjusted EBITDA is expected to grow 10-15% year-over-year in 2022[17] - Free cash flow from continuing operations for Veradigm is expected to be in the range of $110 million to $120 million in 2022[17] - In 2021, Provider revenue accounted for 82% and Payer & Life Sciences revenue accounted for 18% of the total $552 million revenue[16]